| Literature DB >> 28900532 |
Osvaldo C Moreira1,2, Brisamar Estébanez1, Susana Martínez-Florez1, José A de Paz1, María J Cuevas1, Javier González-Gallego1.
Abstract
Aging is a natural, multifactorial and multiorganic phenomenon wherein there are gradual physiological and pathological changes over time. Aging has been associated with a decrease of autophagy capacity and mitochondrial functions, such as biogenesis, dynamics, and mitophagy. These processes are essential for the maintenance of mitochondrial structural integrity and, therefore, for cell life, since mitochondrial dysfunction leads to an impairment of energy metabolism and increased production of reactive oxygen species, which consequently trigger mechanisms of cellular senescence and apoptotic cell death. Moreover, reduced mitochondrial function can contribute to age-associated disease phenotypes in model organisms and humans. Literature data show beneficial effects of exercise on the impairment of mitochondrial biogenesis and dynamics and on the decrease in the mitophagic capacity associated to aging. Thus, exercise could have effects on the major cell signaling pathways that are involved in the mitochondria quality and quantity control in the elderly. Although it is known that several exercise protocols are able to modify the activity and turnover of mitochondria, further studies are necessary in order to better identify the mechanisms of interaction between mitochondrial functions, aging, and physical activity, as well as to analyze possible factors influencing these processes.Entities:
Mesh:
Year: 2017 PMID: 28900532 PMCID: PMC5576425 DOI: 10.1155/2017/2012798
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Mitochondrial biogenesis, dynamics, and mitophagy process. Machinery regulating mitochondrial morphology dynamics can regulate mitophagy initiation, so mitophagy is inhibited by fusion process, mediated via Mfn1/2 and OPA1, and promoted by fission process, mediated via Drp1. Fission process generates polarized mitochondria, which is driven to fusion process, and depolarized mitochondria, which is targeted by mitophagy. In polarized mitochondria, PINK1 is imported into IMM and degraded via proteasome. In depolarized mitochondria, PINK1 is accumulated in OMM. There, PINK1 recruits Parkin from the cytosol by Mfn1 and Mfn2 phosphorylation and phosphorylates ubiquitin and ubiquitin-like domain of Parkin. Then, Parkin ubiquitinates OMM proteins, such as VDAC1, which recruit the p62/SQSTM1 autophagy cargo adaptor. This receptor simultaneously binds to LC3 localized in the nascent phagophore. Furthermore, mitochondrial biogenesis can promote the fusion process, blocking mitophagy, through PGC-1α, which stimulates Mfn2 expression; and mitophagy can inhibit mitochondrial biogenesis via Parkin, whose association with TFAM inhibits the expression of PGC-1α. On the other hand, upon expression, Bnip3 and Nix bind Bcl-2, broking the beclin1/Bcl-2 interaction, so that beclin1 can induce autophagy initiation. Moreover, Bnip3 and Nix are phosphorylated and form homodimers, which integrate in OMM and then bind to LC3. In both cases, the LC3 bond triggers mitochondria to autophagy.
Effect of aging on mitochondrial proteins.
| Reference | Tissue | Subject | Comparative | Results |
|---|---|---|---|---|
| [ | Muscle | Humans | Sedentary and active youths and elderly | NS (mRNA): PGC-1 |
| [ | Carotid arteries | Mouse | Sedentary and active youths and elderly | ↓: PGC-1 |
| ↑: Fis1 | ||||
| [ | Muscle | Humans | Youths/elderly | ↓: PGC-1 |
| NS: Mfn2; Drp1; Fis1 | ||||
| [ | Muscle | Rats | Youths/elderly | ↓ (mRNA and protein): PGC-1 |
| [ | Muscle | Mouse | Youths/elderly | ↑: Nix; LC3 |
| [ | Muscle | Rats | Youths/elderly | ↓: PGC-1 |
| ↑: TFAM; Fis1; Mfn1 | ||||
| [ | Muscle | Humans | Youths/elderly | NS: PGC-1 |
| [ | Muscle | Humans | Youths/elderly | NS: PGC-1 |
| [ | Muscle | Humans | Youths/elderly | NS (mRNA): PGC-1 |
| NS: Parkin; PINK1; VDAC1 | ||||
| [ | Muscle | Humans | Youths and active and sedentary elderly | ↓: PGC-1 |
| [ | Muscle | Humans | Youths and active and sedentary elderly | ↑: PGC-1 |
| NS: Bnip3 (active elderly versus youths) | ||||
| [ | Muscle | Humans | Youths/elderly | NS: VDAC1 |
| [ | Muscle | Mouse | Youths/elderly | ↓: beclin1; Fis1 |
| ↑: Mfn1; Mfn2 | ||||
| NS: PGC-1 | ||||
| [ | Heart | Rats | Youths, old adult, and senescent | ↓: Bnip3; Drp1; Fis1 |
| ↑: OPA1 (old adults versus youths); Mfn2; LC3I | ||||
| NS: beclin1; LC3II | ||||
| [ | Gastrocnemius (G) and triceps (T) muscle | Rats | Youths/elderly | ↓ (G): Drp1; Fis1; beclin1; LC3II; (T): PINK1; VDAC1 |
| ↑ (G): OPA1; Mfn1; VDAC1; (T): OPA1; Mfn1; Drp1; Fis1 | ||||
| NS: (G): PINK1; (T) beclin1; LC3II | ||||
| [ | Muscle | Rats | Youths/elderly | ↓: PGC-1 |
| ↑: TFAM | ||||
| [ | Cerebellum, heart, kidney, and liver | Rats | Youths/elderly | ↑: TFAM |
| NS (heart): TFAM | ||||
| [ | Muscle | Humans | Youths, middle-aged, and elderly | NS: OPA1; Mfn2; Fis1; Drp1; Bnip3; beclin1; LC3II/I |
| [ | Muscle | Mouse | Youths/elderly | ↑: Mfn2/Drp1 |
| NS: OPA; Drp1; Mfn1; Mfn2 | ||||
| [ | Muscle | Rats | Youths/elderly | NS: Drp1; beclin1; LC3II |
| ↑: Parkin; Fis1; OPA1; Mfn2 | ||||
| [ | Brain | Rats | Youths/elderly | ↑: TFAM |
| [ | Liver | Rats | Middle-aged, old (18 m), and very old (28 m) | ↓: TFAM; PGC-1 |
| NS: VDAC | ||||
| [ | Brain, muscle, and liver | Rats | Middle-aged, old (18 m), and very old (28 m) | ↑ (brain): TFAM |
| ↓ (muscle and liver): TFAM | ||||
| [ | Muscle | Mouse | Youths/elderly | ↑: Bnip3; LC3II; LC3II/I |
| ↓: Mfn2 | ||||
| NS: LC3I | ||||
| [ | Brain | Mouse | Youth, middle-aged, and elderly | ↓: TFAM; Drp1; Mfn2 |
| ↑: OPA1; Mfn1 | ||||
| [ | Heart | Humans | Youths/elderly | ↓: PGC-1 |
| [ | Muscle | Humans | Youths/elderly | ↓: LC3II/I |
| NS: beclin1 | ||||
| [ | PBMCs | Humans | Youths/elderly | ↓: LC3II/I; beclin1 |
Effect of exercise on mitochondrial proteins in aging.
| Reference | Tissue | Subject | Comparative | Training | Results |
|---|---|---|---|---|---|
| [ | Muscle | Humans | Sedentary and active youths and elderly | Single bout of treadmill running of 45 min at 70–75% VO2max plus exercise until exhaustion at 90% VO2max | ↓ (mRNA): Fis1; Mfn1 |
| NS: PGC-1 | |||||
| [ | Muscle | Humans | Sedentary elderly and active elderly | 16 weeks of aerobic exercise (bike, walk, run, or row), 3 times/week at 75–80% HR | ↑ (mRNA): PGC-1 |
| NS (mRNA): PGC-1 | |||||
| [ | Muscle | Humans | Trained elderly and untrained elderly | Single bout of high intensity interval exercise on a bicycle ergometer for 20 min at 80% of peak power output | ↑ (mRNA): PGC-1 |
| ↑: PGC-1 | |||||
| NS: PGC-1 | |||||
| [ | Muscle | Humans | Sedentary elderly | Without exercise intervention | ↑ (mRNA): Bnip3; Drp1; Parkin; beclin1 |
| NS (mRNA): Mfn2; PINK1; LC3 | |||||
| NS: beclin1 | |||||
| [ | Carotid arteries | Mouse | Sedentary and active youths and elderly | 10 weeks of voluntary aerobic exercise in a wheel running | NS: PGC-1 |
| [ | Brain | Mouse | Elderly | 3 weeks of treadmill running for 60 min at 15–19 m/min and 10° incline | NS (cortex): PGC-1 |
| NS (striatum): PGC-1 | |||||
| ↑ (cortex): Drp1 | |||||
| [ | Muscle | Humans | Elderly | Single bout of bicycle exercise at 75% VO2max until exhaustion | ↑ (mRNA): PGC-1 |
| NS (mRNA): TFAM | |||||
| [ | Muscle | Humans | Youths/elderly | Without exercise intervention | NS: PGC-1 |
| [ | Muscle | Rats | Youths/elderly | 12 weeks of treadmill running 5 times/week for 45 min at 17.5 m/min and 10° incline | ↑: PGC-1 |
| NS (mRNA): PGC-1 | |||||
| [ | Muscle | Rats | Youths/elderly | 6 weeks of treadmill running for 60 min at 10–22 m/min and 5–10% incline | ↑: PGC-1 |
| ↓: Mfn1 | |||||
| NS: TFAM; Fis1 | |||||
| [ | Muscle | Humans | Youths/elderly | 12 weeks of cycling 3-4 times/week at 60–80% HR reserve for 20–45 min | ↑: PGC-1 |
| [ | Muscle | Humans | Youths/elderly | Without exercise intervention | ↑: PGC-1 |
| [ | Muscle | Rats | Youths/elderly | 7 days of electroestimulation 3 h/day at 10 Hz for 0.1 ms duration | ↑: PGC-1 |
| [ | Muscle | Humans | Youths/elderly | Single bout of resistance training (4 sets of rept. at 75% 1RM with 2 min rest between sets) | ↑ (mRNA): PGC-1 |
| ↑: LC3II (48 h) | |||||
| NS (mRNA): Nix; Bnip3 | |||||
| NS: Parkin; PINK1; VDAC1; beclin1 | |||||
| [ | Muscle | Mouse | Youths/elderly | 6 weeks of voluntary aerobic exercise in wheels running | ↑: PGC-1 |
| [ | Muscle | Mouse | Elderly | Single bout of voluntary aerobic exercise in wheels running for 3 h | NS: OPA1; Mfn2 |
| [ | Muscle | Humans | Youths and active and sedentary elderly | Without exercise intervention | ↓: Bnip3 |
| NS: PGC-1 | |||||
| [ | Muscle | Humans | Elderly | 12 weeks of aerobic exercise for 60 min (20 min cycle ergometer and 40 min treadmill walking) at 80–85% HRmax 5 days/week | ↑ (mRNA): OPA1; Drp1 |
| ↓: phosphorylated Drp1 | |||||
| NS (mRNA): Mfn1; Mfn2; Fis1; PINK1; Parkin | |||||
| [ | Muscle | Humans | Youths/elderly | 14 days of immobilization and 20 sessions of aerobic cycle ergometer training with 48–58 min at 85% HRmax | ↑ (immobilization + training versus immobilization): VDAC1 |
| NS (immobilization + training versus control): VDAC1 | |||||
| [ | Muscle | Humans | Elderly | 24 weeks of combined exercise (walking + strength training + flexibility) 2-3 times/week at moderate intensity | NS (mRNA): Bnip3 |
| ↑ (mRNA): PGC-1 | |||||
| ↑: TFAM | |||||
| [ | Muscle | Humans | Youths/elderly | 5 days of bed rest and 8 weeks of high intensity resistance exercise | ↑: LC3II/I |
| NS: beclin1 | |||||
| [ | PBMCs | Humans | Elderly | 8 weeks of aerobic training | ↑: LC3II/I¸beclin1 |
| [ | PBMCs | Humans | Elderly | 8 weeks of resistance training | ↑: beclin1 |
| NS: LC3II/I |